Holen Sie sich die Stockscreener-App
57.38
0.45%
0.19
Schlusskurs vom Vortag:
$57.19
Offen:
$57.17
24-Stunden-Volumen:
482.55K
Relative Volume:
0.20
Marktkapitalisierung:
$7.17B
Einnahmen:
$692.26M
Nettoeinkommen (Verlust:
$-512.41M
KGV:
-13.53
EPS:
-4.24
Netto-Cashflow:
$-274.36M
1W Leistung:
+1.15%
1M Leistung:
-3.40%
6M Leistung:
+31.01%
1J Leistung:
+129.07%
1-Tages-Spanne:
$56.95
$58.01
1-Wochen-Bereich:
$53.40
$58.75
52-Wochen-Spanne:
$20.14
$68.00
Guardant Health Inc Stock (GH) Company Profile
Firmenname
Guardant Health Inc
Sektor
Branche
Telefon
855-698-8887
Adresse
3100 HANOVER STREET, PALO ALTO
Vergleichen Sie GH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
57.48 | 7.13B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
477.17 | 178.47B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
194.45 | 138.15B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
645.70 | 51.27B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
127.97 | 35.93B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
188.93 | 31.74B | 15.70B | 1.24B | 2.01B | 6.91 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Eingeleitet | Mizuho | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-28 | Hochstufung | Guggenheim | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-24 | Fortgesetzt | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-27 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-26 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-03-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-11-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-06 | Eingeleitet | Stephens | Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-28 | Fortgesetzt | BTIG Research | Buy |
| 2022-02-24 | Bestätigt | Canaccord Genuity | Buy |
| 2022-02-24 | Bestätigt | Citigroup | Buy |
| 2022-02-24 | Bestätigt | Cowen | Outperform |
| 2022-02-24 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-24 | Bestätigt | SVB Leerink | Outperform |
| 2022-02-24 | Bestätigt | Stifel | Buy |
| 2022-02-24 | Bestätigt | Wells Fargo | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-11 | Eingeleitet | Stifel | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-06-12 | Eingeleitet | BTIG Research | Buy |
| 2020-02-21 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-08-07 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-04-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | Bestätigt | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-29 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Guardant Health Inc Aktie (GH) Neueste Nachrichten
Guardant Health Inc. (GH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Q2 Earnings Recap: Guardant Health (NASDAQ:GH) Tops Testing & Diagnostics Services Stocks - Yahoo Finance
Guardant Health (GH) director Potter sells $1446 in stock - Investing.com
Jobs Data: Can Guardant Health Inc maintain its current growth rateQuarterly Profit Report & Real-Time Volume Spike Alerts - خودرو بانک
Guardant Health (GH) director Potter sells $1446 in stock By Investing.com - Investing.com UK
Aug Update: What is the implied volatility of Guardant Health IncPortfolio Gains Summary & Daily Market Momentum Tracking - خودرو بانک
Rhumbline Advisers Grows Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health announces prelim Q4 revenue above estimate - MSN
Intech Investment Management LLC Boosts Position in Guardant Health, Inc. $GH - MarketBeat
Aug Sentiment: Does Guardant Health Inc. meet Warren Buffett’s criteriaQuarterly Market Summary & Safe Capital Investment Plans - خودرو بانک
Volume Summary: Is Guardant Health Inc. stock showing strong momentumTrade Risk Report & Fast Moving Stock Watchlists - خودرو بانک
Guardant Health (NASDAQ:GH) Director Sells $117,256.40 in Stock - MarketBeat
Guardant Health (NASDAQ:GH) CEO Sells $17,835,000.00 in Stock - MarketBeat
Rally Mode: Can Guardant Health Inc keep up with sector leadersWeekly Market Outlook & Free Community Consensus Stock Picks - خودرو بانک
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $118.30 Million Position in Guardant Health, Inc. $GH - MarketBeat
Gains Recap: Can Guardant Health Inc navigate macro headwindsPortfolio Risk Summary & Stepwise Entry and Exit Trade Signals - خودرو بانک
Former HHS secretary Alex Azar joins Guardant Health’s board By Investing.com - Investing.com Australia
Guardant Health (GH) director Hidalgo Medina sells $117,250 in stock - Investing.com
Alex M. Azar Ii Joins Guardant Health Board Of Directors - TradingView
Former HHS secretary Alex Azar joins Guardant Health’s board - Investing.com
Alex M. Azar II Joins Guardant Health Board of Directors - Yahoo Finance
Valuation Update: Is Guardant Health Inc. a good ESG investment2025 Market Trends & Free Community Supported Trade Ideas - خودرو بانک
Weekly Recap: Can Guardant Health Inc keep up with sector leadersJuly 2025 Technicals & Fast Gain Swing Alerts - خودرو بانک
Fred Alger Management LLC Boosts Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
United States Multi Cancer Early Detection Testing Market Set - openPR.com
Guardant Health (NASDAQ:GH) Shares Gap Down Following Insider Selling - MarketBeat
Have Insiders Sold Guardant Health Shares Recently? - simplywall.st
Osterweis Capital Management Inc. Makes New $12.63 Million Investment in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. $GH Shares Sold by Adalta Capital Management LLC - MarketBeat
Guardant Health, Inc. $GH Shares Sold by SWS Partners - MarketBeat
Guardant Health, Inc. $GH Shares Sold by Temasek Holdings Private Ltd - MarketBeat
Shield Blood Test Yields High Sensitivity, Specificity for CRC Screening in Expansion Cohort of Average-Risk Adults - OncLive
Parkman Healthcare Partners LLC Makes New Investment in Guardant Health, Inc. $GH - MarketBeat
More Blood Tests for Cancer Hit the Market - Barron's
Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership - Yahoo Finance
Guardant Health, Inc. $GH Holdings Cut by Exome Asset Management LLC - MarketBeat
Guardant Health, Inc. $GH Stock Position Decreased by Cubist Systematic Strategies LLC - MarketBeat
Select Medical, Guardant Health, Artivion, PacBio, and Intuitive Surgical Shares Are Falling, What You Need To Know - Yahoo Finance
Guardant Health (GH) Soars 21% After Partnership With PathGroup - Yahoo Finance
Guardant Health gains amid $292.5M verdict against Natera over false advertising claims (update) - MSN
Cinctive Capital Management LP Makes New Investment in Guardant Health, Inc. $GH - MarketBeat
Canada Pension Plan Investment Board Has $3.90 Million Stock Position in Guardant Health, Inc. $GH - MarketBeat
Ieq Capital LLC Takes $660,000 Position in Guardant Health, Inc. $GH - MarketBeat
Eventide Asset Management LLC Reduces Holdings in Guardant Health, Inc. $GH - MarketBeat
Screener Results Flag Guardant Health Inc. as Oversold2025 Pullback Review & Risk Controlled Stock Pick Alerts - beatles.ru
Guardant Health at Morgan Stanley Conference: Innovations in Cancer Diagnostics - Investing.com Canada
Is Guardant Health Inc. a good ESG investmentJuly 2025 Reactions & Weekly Top Performers Watchlists - beatles.ru
Guardant Health partners with PathGroup to expand blood test screening By Investing.com - Investing.com South Africa
Candlestick Reversal Detected on Guardant Health Inc.’s ChartJuly 2025 Chart Watch & Low Drawdown Trading Techniques - beatles.ru
Finanzdaten der Guardant Health Inc-Aktie (GH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Guardant Health Inc-Aktie (GH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tariq Musa | Director |
Sep 17 '25 |
Sale |
55.63 |
116 |
6,453 |
7,591 |
| POTTER MYRTLE S | Director |
Sep 15 '25 |
Option Exercise |
0.00 |
68 |
0 |
18,307 |
| POTTER MYRTLE S | Director |
Sep 17 '25 |
Sale |
55.63 |
26 |
1,446 |
18,281 |
| Saia John G. | Chief Legal Officer |
Sep 15 '25 |
Option Exercise |
0.00 |
1,019 |
0 |
45,967 |
| Kalia Kumud | Chief Information Officer |
Sep 15 '25 |
Option Exercise |
0.00 |
638 |
0 |
19,488 |
| Freeman Chris | Chief Commercial Officer |
Sep 15 '25 |
Option Exercise |
0.00 |
1,402 |
0 |
50,223 |
| EAGLE CRAIG | Chief Medical Officer |
Sep 15 '25 |
Option Exercise |
0.00 |
1,402 |
0 |
38,193 |
| Bell Michael Brian | Chief Financial Officer |
Sep 15 '25 |
Option Exercise |
0.00 |
3,272 |
0 |
46,300 |
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):